2012;126:1452 60. 25. Kammerlander AA, Wiesinger M, Duca F, et al. Diagnostic and prognos- tic utility of cardiac magnetic resonance imaging in aortic regurgitation. JACC Cardiovasc Imaging. 2019;12:1474 83. 26. Teague SM, Heinsimer JA, Anderson JL, et al. Quantification of aortic re- gurgitation utilizing continuous wave Doppler ultrasound. J Am Coll Car- diol. 1986;8:592 9. 27. Attenhofer Jost CH, Turina J, Mayer K, et al. Echocardiography in the eval- uation of systolic murmurs of unknown cause. Am J Med. 2000;108:614 20. 28. Benjelloun H, Cranney GB, Kirk KA, et al. Interstudy reproducibility of bi- plane cine nuclear magnetic resonance measurements of left ventricular function. Am J Cardiol. 1991;67:1413 20. 29. Buser PT, Auffermann W, Holt WW, et al. Noninvasive evaluation of global left ventricular function with use of cine nuclear magnetic resonance. J Am Coll Cardiol. 1989;13:1294 300. 30. Van Rossum AC, Visser FC, Sprenger M, et al. Evaluation of magnetic resonance imaging for determination of left ventricular ejection fraction and comparison with angiography. Am J Cardiol. 1988;62:628 33. 4.3.2. Medical Therapy 1. Evangelista A, Tornos P, Sambola A, et al. Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med. 2005;353:1342 9. 2. Scognamiglio R, Rahimtoola SH, Fasoli G, et al. Nifedipine in asymptom- atic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med. 1994;331:689 94. 3. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e596 646. 4. Yancy CW, Jessup M, Bozkurt B, et al. 